University of Michigan Comprehensive Cancer Center
Rogel Cancer Center
Ann Arbor, MI
Filters
- PI3K Inhibitor
- Tyrosine Kinase (TK) Inhibitor
- CDK6
- Phase 2
Accepting patients
LEADER Neoadjuvant Screening Trial: LCMC4 Evaluation of Actionable Drivers in Early Stage Lung Cancers
Learn more- Observational Trial
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trialsAccepting patients
NCI-COG Pediatric MATCH
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
Learn more- ALK Inhibitor
- EphA2 Inhibitor
- Phase 2
Accepting patients
NAUTIKA1: Multicenter, Phase II, Neoadjuvant and Adjuvant Study of Multiple Therapies in Biomarker-Selected Patients With Resectable Stages IB-III Non-Small Cell Lung Cancer
Learn more- Phase 2
Accepting patients
TAPUR
Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer (TAPUR)
Learn more- ROS1 Inhibitor
- Phase 2